Weekly Event Preview | Insilico’s Dr. Alex Aliper to attend dual Hong Kong summits to unlock AI-driven healthcare innovations
Meeting Announcement
Updates every hour. Last Updated: 31-Oct-2026 13:15 ET (31-Oct-2026 17:15 GMT/UTC)
August 24–25, 2026 | Hong Kong, China
Alex Aliper, PhD, Co-founder and President of Insilico Medicine, has been invited to attend the Global Unicorn Summit in Hong Kong on August 24. He will participate in a panel discussion titled "What Will Power the Next Wave of Global Growth?" from 15:00 to 15:50.
August 26–28, 2026 | Hong Kong, China
Alex Aliper, PhD, Co-founder and President of Insilico Medicine, has been invited to attend the MedTech World Asia summit in Hong Kong on August 27. He will deliver remarks and join a panel discussion titled "AI & Precision Medicine: Turning Data into Targeted Care" from 12:35 to 13:10. Subsequently, Dr.Aliper will attend a luncheon titled "Cross-Border Exit Architecture for Asian MedTech Companies" on August 28, from 12:45 pm to 13:45 pm.
Inherited retinal disorders (IRDs) lead to vision loss and, in many cases, to complete blindness in those affected. Professor Uwe Wolfrum of the Institute of Molecular Physiology at Johannes Gutenberg University Mainz (JGU) is a leading researcher on a specific form of these disorders: the human Usher syndrome. In recognition of his scientific achievements in ophthalmology and vision research, Professor Wolfrum was recently honored by the renowned Institute of Ophthalmology at University College London (UCL).
Using in vivo mouse models and primary in vitro alveolar epithelial cell cultures, researchers found influenza A virus (H1N1) preferentially infects alveolar type 2 (AT2) cells in the early stage of lung alveolar infection. Compared to alveolar type 1 (AT1) cells, AT2 cells exhibit significantly delayed production of type I/III interferons, interferon-stimulated genes and chemokines, which drives elevated viral replication and higher infection susceptibility.
PCOS is a common endocrine disorder in women of reproductive age, imposing substantial health and economic burdens worldwide. In a recent large-scale study involving more than 14 million pregnant women across Chinese Mainland, researchers explored how the prevalence of PCOS has increased since the implementation of the universal two-child policy. The article discusses how pregnant women with PCOS face higher risks of various adverse maternal and neonatal outcomes, highlighting the need for targeted obstetric management.
Japan has one of the world’s longest-living populations, yet predicting which octogenarians will lose their independence remains difficult. Now, researchers identify two blood proteins—beta-2-microglobulin and cystatin C—that are consistently associated with future disability in adults aged 85 years and older. The findings, independently replicated in an Italian aging cohort, suggest that kidney dysfunction and chronic inflammation contribute to disability risk and could support earlier preventive interventions in rapidly aging populations worldwide.
About one in five patients with coronary artery disease show little or no measurable improvement in their exercise capacity despite completing a full cardiac rehabilitation (CR) program. Identification of these “non-responders” before training could help in the better design of the treatment strategy. In a new study, researchers used machine learning model to predict who would benefit from exercise-based CR. Overall, the study points toward a more personalized model of CR.
Robot-assisted knee replacement surgery is more precise than a surgeon on their own, but does not currently lead to improvements in patient outcomes, according to the RACER-Knee trial, the world's largest clinical study of its kind. This trial makes an important contribution to the evidence on robotics in health care and where future advances and research should focus. The trial, coordinated by the University of Warwick and University Hospitals Coventry and Warwickshire (UHCW) NHS Trust, is published in The Lancet, the world's oldest and best-known general medical journal.